Priti Ranjan, MD
Family Medicine · Plano, TXNPI 1356579247
Payments from drug & device makers
Across 69 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$218
- Lilly USA, LLC$174
- Merck$125
- Exact Sciences$113
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$100
- Pfizer$92
- plus $429 from 15 others
What the payments were for
- Food & beverage$1,251100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $218 |
| Lilly USA, LLC | 11 | $174 |
| Merck | 8 | $125 |
| Exact Sciences | 6 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $100 |
| Pfizer | 4 | $92 |
| Abbott | 4 | $85 |
| Bayer | 3 | $50 |
| Medtronic | 2 | $36 |
| Si-bone, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $29 |
| Amgen | 1 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Novo Nordisk | 1 | $16 |
| Renalytix AI, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Linus Health, Inc. | 1 | $14 |
| GSK | 1 | $14 |
How this compares
$1,251 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $1,445 |
| Atorvastatin Calcium | 84 | $673 |
| Levothyroxine Sodium | 62 | $659 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 26 | $514 |
| Gabapentin | 28 | $472 |
| Amlodipine Besylate | 65 | $437 |
| Azelastine Hcl | 16 | $339 |
| Cyclobenzaprine Hcl | 11 | $323 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 23 | $303 |
| Pantoprazole Sodium | 24 | $291 |
| Valsartan | 13 | $259 |
| Carvedilol | 21 | $252 |
| Metformin Hcl | 38 | $247 |
| Omeprazole | 18 | $239 |
| Alprazolam | 54 | $219 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Plano
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.